Intensity Therapeutics, Inc. (INTS)
3.35
-0.03
(-0.89%)
USD |
NASDAQ |
Oct 16, 16:00
3.27
-0.08
(-2.39%)
After-Hours: 20:00
Intensity Therapeutics Net Income (Quarterly) : -3.007M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.007M |
| March 31, 2026 | -2.434M |
| December 31, 2025 | -3.051M |
| September 30, 2025 | -2.671M |
| June 30, 2025 | -2.537M |
| March 31, 2025 | -3.347M |
| December 31, 2024 | -3.181M |
| September 30, 2024 | -3.513M |
| June 30, 2024 | -4.971M |
| March 31, 2024 | -4.603M |
| December 31, 2023 | -3.171M |
| Date | Value |
|---|---|
| September 30, 2023 | -2.330M |
| June 30, 2023 | -3.700M |
| March 31, 2023 | -1.336M |
| December 31, 2022 | -1.510M |
| September 30, 2022 | -1.775M |
| June 30, 2022 | -1.928M |
| March 31, 2022 | -2.369M |
| December 31, 2021 | -2.401M |
| March 31, 2021 | -1.479M |
| December 31, 2020 | -1.635M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.007M |
| EPS Diluted (Quarterly) | -1.111 |
| Enterprise Value | 0.4338M |
| Earnings Yield | -144.2% |
| Normalized Earnings Yield | -144.22 |